Cargando…

Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411013/
https://www.ncbi.nlm.nih.gov/pubmed/25960676
http://dx.doi.org/10.2147/IJWH.S85889
_version_ 1782368401857970176
collection PubMed
description
format Online
Article
Text
id pubmed-4411013
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44110132015-05-08 Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum] Int J Womens Health Corrigendum Dove Medical Press 2015-04-16 /pmc/articles/PMC4411013/ /pubmed/25960676 http://dx.doi.org/10.2147/IJWH.S85889 Text en © 2015 Doherty and Morris. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Corrigendum
Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
title Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
title_full Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
title_fullStr Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
title_full_unstemmed Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
title_short Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
title_sort eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [corrigendum]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411013/
https://www.ncbi.nlm.nih.gov/pubmed/25960676
http://dx.doi.org/10.2147/IJWH.S85889